img

Global Blood Transfusion Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Blood Transfusion Diagnostics Market Research Report 2024

Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.
According to MRAResearch’s new survey, global Blood Transfusion Diagnostics market is projected to reach US$ 4338.7 million in 2033, increasing from US$ 3034.7 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blood Transfusion Diagnostics market research.
Key companies engaged in the Blood Transfusion Diagnostics industry include Grifols, Thermo Fisher Scientific, Roche, bioMérieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio and DiaSorin(American Standard Companies), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Blood Transfusion Diagnostics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Blood Transfusion Diagnostics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Blood Transfusion Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin(American Standard Companies)
Beckman Coulter
Diagast
Abbott
BAG Health Care
Quidel
Segment by Type
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology

Segment by Application


Hospitals
Clinics
Blood Banks
Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Blood Transfusion Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Transfusion Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 ELISA
1.2.3 NAT
1.2.4 Western Blot Assays
1.2.5 Fluorescence Assay
1.2.6 Other Technology
1.3 Market by Application
1.3.1 Global Blood Transfusion Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Blood Banks
1.3.5 Laboratories
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Transfusion Diagnostics Market Perspective (2018-2033)
2.2 Blood Transfusion Diagnostics Growth Trends by Region
2.2.1 Global Blood Transfusion Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Blood Transfusion Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Blood Transfusion Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Blood Transfusion Diagnostics Market Dynamics
2.3.1 Blood Transfusion Diagnostics Industry Trends
2.3.2 Blood Transfusion Diagnostics Market Drivers
2.3.3 Blood Transfusion Diagnostics Market Challenges
2.3.4 Blood Transfusion Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Transfusion Diagnostics Players by Revenue
3.1.1 Global Top Blood Transfusion Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Blood Transfusion Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Blood Transfusion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Transfusion Diagnostics Revenue
3.4 Global Blood Transfusion Diagnostics Market Concentration Ratio
3.4.1 Global Blood Transfusion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Transfusion Diagnostics Revenue in 2022
3.5 Blood Transfusion Diagnostics Key Players Head office and Area Served
3.6 Key Players Blood Transfusion Diagnostics Product Solution and Service
3.7 Date of Enter into Blood Transfusion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Transfusion Diagnostics Breakdown Data by Type
4.1 Global Blood Transfusion Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2024-2033)
5 Blood Transfusion Diagnostics Breakdown Data by Application
5.1 Global Blood Transfusion Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Blood Transfusion Diagnostics Market Size (2018-2033)
6.2 North America Blood Transfusion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Blood Transfusion Diagnostics Market Size by Country (2018-2023)
6.4 North America Blood Transfusion Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Transfusion Diagnostics Market Size (2018-2033)
7.2 Europe Blood Transfusion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Blood Transfusion Diagnostics Market Size by Country (2018-2023)
7.4 Europe Blood Transfusion Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Transfusion Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Blood Transfusion Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Transfusion Diagnostics Market Size (2018-2033)
9.2 Latin America Blood Transfusion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Blood Transfusion Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Blood Transfusion Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Transfusion Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Blood Transfusion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Transfusion Diagnostics Introduction
11.1.4 Grifols Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.1.5 Grifols Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Blood Transfusion Diagnostics Introduction
11.3.4 Roche Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.3.5 Roche Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Detail
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Blood Transfusion Diagnostics Introduction
11.4.4 bioMérieux Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.4.5 bioMérieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Blood Transfusion Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.5.5 Bio-Rad Recent Development
11.6 Ortho Clinical Diagnostics
11.6.1 Ortho Clinical Diagnostics Company Detail
11.6.2 Ortho Clinical Diagnostics Business Overview
11.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Introduction
11.6.4 Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.6.5 Ortho Clinical Diagnostics Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Blood Transfusion Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.7.5 Becton Dickinson Recent Development
11.8 Fujirebio
11.8.1 Fujirebio Company Detail
11.8.2 Fujirebio Business Overview
11.8.3 Fujirebio Blood Transfusion Diagnostics Introduction
11.8.4 Fujirebio Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.8.5 Fujirebio Recent Development
11.9 DiaSorin(American Standard Companies)
11.9.1 DiaSorin(American Standard Companies) Company Detail
11.9.2 DiaSorin(American Standard Companies) Business Overview
11.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Introduction
11.9.4 DiaSorin(American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.9.5 DiaSorin(American Standard Companies) Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Detail
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Blood Transfusion Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.10.5 Beckman Coulter Recent Development
11.11 Diagast
11.11.1 Diagast Company Detail
11.11.2 Diagast Business Overview
11.11.3 Diagast Blood Transfusion Diagnostics Introduction
11.11.4 Diagast Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.11.5 Diagast Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Blood Transfusion Diagnostics Introduction
11.12.4 Abbott Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.12.5 Abbott Recent Development
11.13 BAG Health Care
11.13.1 BAG Health Care Company Detail
11.13.2 BAG Health Care Business Overview
11.13.3 BAG Health Care Blood Transfusion Diagnostics Introduction
11.13.4 BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.13.5 BAG Health Care Recent Development
11.14 Quidel
11.14.1 Quidel Company Detail
11.14.2 Quidel Business Overview
11.14.3 Quidel Blood Transfusion Diagnostics Introduction
11.14.4 Quidel Revenue in Blood Transfusion Diagnostics Business (2018-2023)
11.14.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Blood Transfusion Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of ELISA
Table 3. Key Players of NAT
Table 4. Key Players of Western Blot Assays
Table 5. Key Players of Fluorescence Assay
Table 6. Key Players of Other Technology
Table 7. Global Blood Transfusion Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Blood Transfusion Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Blood Transfusion Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Blood Transfusion Diagnostics Market Share by Region (2018-2023)
Table 11. Global Blood Transfusion Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Blood Transfusion Diagnostics Market Share by Region (2024-2033)
Table 13. Blood Transfusion Diagnostics Market Trends
Table 14. Blood Transfusion Diagnostics Market Drivers
Table 15. Blood Transfusion Diagnostics Market Challenges
Table 16. Blood Transfusion Diagnostics Market Restraints
Table 17. Global Blood Transfusion Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Blood Transfusion Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top Blood Transfusion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Transfusion Diagnostics as of 2022)
Table 20. Ranking of Global Top Blood Transfusion Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Blood Transfusion Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Blood Transfusion Diagnostics Product Solution and Service
Table 24. Date of Enter into Blood Transfusion Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Transfusion Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Blood Transfusion Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Blood Transfusion Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global Blood Transfusion Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Blood Transfusion Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Blood Transfusion Diagnostics Revenue Market Share by Application (2024-2033)
Table 34. North America Blood Transfusion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Blood Transfusion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Blood Transfusion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Blood Transfusion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Blood Transfusion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Blood Transfusion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Blood Transfusion Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Blood Transfusion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Blood Transfusion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Blood Transfusion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Blood Transfusion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Grifols Company Detail
Table 50. Grifols Business Overview
Table 51. Grifols Blood Transfusion Diagnostics Product
Table 52. Grifols Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Grifols Recent Development
Table 54. Thermo Fisher Scientific Company Detail
Table 55. Thermo Fisher Scientific Business Overview
Table 56. Thermo Fisher Scientific Blood Transfusion Diagnostics Product
Table 57. Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Thermo Fisher Scientific Recent Development
Table 59. Roche Company Detail
Table 60. Roche Business Overview
Table 61. Roche Blood Transfusion Diagnostics Product
Table 62. Roche Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 63. Roche Recent Development
Table 64. bioMérieux Company Detail
Table 65. bioMérieux Business Overview
Table 66. bioMérieux Blood Transfusion Diagnostics Product
Table 67. bioMérieux Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 68. bioMérieux Recent Development
Table 69. Bio-Rad Company Detail
Table 70. Bio-Rad Business Overview
Table 71. Bio-Rad Blood Transfusion Diagnostics Product
Table 72. Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Bio-Rad Recent Development
Table 74. Ortho Clinical Diagnostics Company Detail
Table 75. Ortho Clinical Diagnostics Business Overview
Table 76. Ortho Clinical Diagnostics Blood Transfusion Diagnostics Product
Table 77. Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Ortho Clinical Diagnostics Recent Development
Table 79. Becton Dickinson Company Detail
Table 80. Becton Dickinson Business Overview
Table 81. Becton Dickinson Blood Transfusion Diagnostics Product
Table 82. Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 83. Becton Dickinson Recent Development
Table 84. Fujirebio Company Detail
Table 85. Fujirebio Business Overview
Table 86. Fujirebio Blood Transfusion Diagnostics Product
Table 87. Fujirebio Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 88. Fujirebio Recent Development
Table 89. DiaSorin(American Standard Companies) Company Detail
Table 90. DiaSorin(American Standard Companies) Business Overview
Table 91. DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Product
Table 92. DiaSorin(American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 93. DiaSorin(American Standard Companies) Recent Development
Table 94. Beckman Coulter Company Detail
Table 95. Beckman Coulter Business Overview
Table 96. Beckman Coulter Blood Transfusion Diagnostics Product
Table 97. Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Beckman Coulter Recent Development
Table 99. Diagast Company Detail
Table 100. Diagast Business Overview
Table 101. Diagast Blood Transfusion Diagnostics Product
Table 102. Diagast Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Diagast Recent Development
Table 104. Abbott Company Detail
Table 105. Abbott Business Overview
Table 106. Abbott Blood Transfusion Diagnostics Product
Table 107. Abbott Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Abbott Recent Development
Table 109. BAG Health Care Company Detail
Table 110. BAG Health Care Business Overview
Table 111. BAG Health Care Blood Transfusion Diagnostics Product
Table 112. BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 113. BAG Health Care Recent Development
Table 114. Quidel Company Detail
Table 115. Quidel Business Overview
Table 116. Quidel Blood Transfusion Diagnostics Product
Table 117. Quidel Revenue in Blood Transfusion Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Quidel Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Transfusion Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Blood Transfusion Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. ELISA Features
Figure 4. NAT Features
Figure 5. Western Blot Assays Features
Figure 6. Fluorescence Assay Features
Figure 7. Other Technology Features
Figure 8. Global Blood Transfusion Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Blood Transfusion Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Blood Banks Case Studies
Figure 13. Laboratories Case Studies
Figure 14. Other Case Studies
Figure 15. Blood Transfusion Diagnostics Report Years Considered
Figure 16. Global Blood Transfusion Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Blood Transfusion Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Blood Transfusion Diagnostics Market Share by Region: 2022 VS 2033
Figure 19. Global Blood Transfusion Diagnostics Market Share by Players in 2022
Figure 20. Global Top Blood Transfusion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Transfusion Diagnostics as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Blood Transfusion Diagnostics Revenue in 2022
Figure 22. North America Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Blood Transfusion Diagnostics Market Share by Country (2018-2033)
Figure 24. United States Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Blood Transfusion Diagnostics Market Share by Country (2018-2033)
Figure 28. Germany Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Blood Transfusion Diagnostics Market Share by Region (2018-2033)
Figure 36. China Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Blood Transfusion Diagnostics Market Share by Country (2018-2033)
Figure 44. Mexico Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Blood Transfusion Diagnostics Market Share by Country (2018-2033)
Figure 48. Turkey Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Blood Transfusion Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Grifols Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 53. bioMérieux Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 54. Bio-Rad Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 55. Ortho Clinical Diagnostics Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 56. Becton Dickinson Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 57. Fujirebio Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 58. DiaSorin(American Standard Companies) Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 59. Beckman Coulter Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 60. Diagast Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 61. Abbott Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 62. BAG Health Care Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 63. Quidel Revenue Growth Rate in Blood Transfusion Diagnostics Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed